[Prostaglandin for prevention of blood coagulation due to hemodialysis].
Kitazawa
K
K
Department of Nephrology, Showa University School of Medicine.
Kobayashi
K
K
Sugisaki
T
T
D000527:Alprostadil / Q000494:pharmacology / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000517:prevention & control*; D015232:Dinoprostone / Q000494:pharmacology / Q000627:therapeutic use; D011464:Epoprostenol / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D015230:Prostaglandin D2 / Q000494:pharmacology / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects*
C038991:R 59274; D006493:Heparin; D011464:Epoprostenol; D000527:Alprostadil; D015232:Dinoprostone; C035847:ataprost; D015230:Prostaglandin D2